Wendt, Michael K <br/><br/>
Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.  [electronic resource] 

 -  Breast cancer research : BCR  Mar 2014 
 - R24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr3623  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alternative Splicing<br/>Animals<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--genetics<br/>Cadherins--genetics<br/>Cell Line<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>MCF-7 Cells<br/>Mammary Glands, Animal--cytology<br/>Mammary Neoplasms, Experimental--genetics<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Metastasis<br/>Oligonucleotide Array Sequence Analysis<br/>Phenylurea Compounds--pharmacology<br/>Protein Isoforms--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Receptor, Fibroblast Growth Factor, Type 1--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transforming Growth Factor beta1--pharmacology